Conejo-Garcia JR - Search Results

1

Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rbeta1 isoform that enhances DC migration.

Robinson RT, Khader SA, Martino CA, Fountain JJ, Teixeira-Coelho M, Pearl JE, Smiley ST, Winslow GM, Woodland DL, Walter MJ, Conejo-Garcia JR, Gubler U, Cooper AM. Robinson RT, et al. J Exp Med. 2010 Mar 15;207(3):591-605. doi: 10.1084/jem.20091085. Epub 2010 Mar 8. J Exp Med. 2010. PMID: 20212068 Free PMC article.

2

Ovarian cancer progression is controlled by phenotypic changes in dendritic cells.

Scarlett UK, Rutkowski MR, Rauwerdink AM, Fields J, Escovar-Fadul X, Baird J, Cubillos-Ruiz JR, Jacobs AC, Gonzalez JL, Weaver J, Fiering S, Conejo-Garcia JR. Scarlett UK, et al. J Exp Med. 2012 Mar 12;209(3):495-506. doi: 10.1084/jem.20111413. Epub 2012 Feb 20. J Exp Med. 2012. PMID: 22351930 Free PMC article.

3

Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A.

Conejo-Garcia JR, Benencia F, Courreges MC, Kang E, Mohamed-Hadley A, Buckanovich RJ, Holtz DO, Jenkins A, Na H, Zhang L, Wagner DS, Katsaros D, Caroll R, Coukos G. Conejo-Garcia JR, et al. Nat Med. 2004 Sep;10(9):950-8. doi: 10.1038/nm1097. Epub 2004 Aug 29. Nat Med. 2004. PMID: 15334073 Free article.

4

Vascular leukocytes: a population with angiogenic and immunossuppressive properties highly represented in ovarian cancer.

Coukos G, Conejo-Garcia JR, Buckanovich R, Benencia F. Coukos G, et al. Adv Exp Med Biol. 2007;590:185-93. doi: 10.1007/978-0-387-34814-8_13. Adv Exp Med Biol. 2007. PMID: 17191386 Review. No abstract available.

5

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W. Curiel TJ, et al. Nat Med. 2004 Sep;10(9):942-9. doi: 10.1038/nm1093. Epub 2004 Aug 22. Nat Med. 2004. PMID: 15322536 Free article.

6

Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes.

Cubillos-Ruiz JR, Rutkowski M, Conejo-Garcia JR. Cubillos-Ruiz JR, et al. Cell Cycle. 2010 Jan 15;9(2):260-8. doi: 10.4161/cc.9.2.10430. Epub 2010 Jan 26. Cell Cycle. 2010. PMID: 20023378 Free PMC article. Review.

7

Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer.

Cubillos-Ruiz JR, Baird JR, Tesone AJ, Rutkowski MR, Scarlett UK, Camposeco-Jacobs AL, Anadon-Arnillas J, Harwood NM, Korc M, Fiering SN, Sempere LF, Conejo-Garcia JR. Cubillos-Ruiz JR, et al. Cancer Res. 2012 Apr 1;72(7):1683-93. doi: 10.1158/0008-5472.CAN-11-3160. Epub 2012 Feb 3. Cancer Res. 2012. PMID: 22307839 Free PMC article.

8

Double agents in the war on cancer: leukocytes govern ovarian cancer progression.

Scarlett UK, Conejo-Garcia JR. Scarlett UK, et al. Oncotarget. 2012 Mar;3(3):226-7. doi: 10.18632/oncotarget.478. Oncotarget. 2012. PMID: 22538964 Free PMC article.

9

Anti-tumor immunity: myeloid leukocytes control the immune landscape.

Rutkowski MR, Stephen TL, Conejo-Garcia JR. Rutkowski MR, et al. Cell Immunol. 2012 Jul-Aug;278(1-2):21-6. doi: 10.1016/j.cellimm.2012.06.014. Epub 2012 Jul 14. Cell Immunol. 2012. PMID: 23121972 Free PMC article. Review.

10

Modulating the tumor immune microenvironment as an ovarian cancer treatment strategy.

Scarlett UK, Conejo-Garcia JR. Scarlett UK, et al. Expert Rev Obstet Gynecol. 2012 Sep 1;7(5):413-419. doi: 10.1586/eog.12.41. Expert Rev Obstet Gynecol. 2012. PMID: 24039628 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page